Nektar Therapeutics (NKTR) Misses Q1 EPS by 182c
Tweet
Share
E-mail
Get Alerts NKTR Hot Sheet
Price: $59.38 +0.29%
Revenue Growth %: -7.1%
Financial Fact:
Cost of goods sold: 7.03M
Today's EPS Names:
PLCE, COE, JVA, More
Revenue Growth %: -7.1%
Financial Fact:
Cost of goods sold: 7.03M
Today's EPS Names:
PLCE, COE, JVA, More
Join SI Premium – FREE
Nektar Therapeutics (NASDAQ: NKTR) reported Q1 EPS of ($1.82). Revenue for the quarter came in at $10.9 million.
For earnings history and earnings-related data on Nektar Therapeutics (NKTR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Evercore ISI Reiterates Underperform Rating on Lennar (LEN)
- Celldex reports sustained angioedema improvements 7 months post-treatment
- Nvidia pitches Vera CPU to Chinese clients with August delivery target
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
